Company news
Thx Pharma (EURONEXT:ALTHX) news
Thx Pharma news releases on 6ix. Latest, Sep 29, 2026: Thx Pharma : THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
Press releases & updates
Thx Pharma : THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
September 29, 2026
THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
September 28, 2026
THX PHARMA ANNONCE SES RESULTATS FINANCIERS DU PREMIER SEMESTRE 2026
September 28, 2026
Rapport semestriel THX Pharma
September 28, 2026
Thx Pharma : Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
September 9, 2026
Thx Pharma : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
September 8, 2026
Thx Pharma : THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten Disease (CLN3)
September 1, 2026
Thx Pharma : THX Pharma Reports Cash Position as of June 30, 2026
July 9, 2026
Thx Pharma : THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
June 23, 2026
Thx Pharma : Allinvest Securities Initiates Analyst Coverage on THX Pharma with Buy Recommendation
June 16, 2026
Thx Pharma : THX Pharma (Theranexus) and Exeltis secure EMA approval of the paediatric investigation plan (PIP) for TX01, unlocking the PUMA registration pathway
June 9, 2026
THX Pharma : Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
April 28, 2026
Thx Pharma : THX Pharma Publishes Its 2025 Annual Results, Cash Position as of March 31, 2026, and Provides a Business Update
April 28, 2026
THX Pharma : announces the publication of its letter to shareholders
March 25, 2026
THX Pharma : Reports Its Cash Position as of December 31, 2025
February 19, 2026
THX Pharma : to Host a Webinar to Discuss Its Strategic Agreement with Biocodex
February 12, 2026
THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases
February 10, 2026
Thx Pharma : THX Pharma Announces its 2026 Financial Calendar
January 20, 2026
THX Pharma : Shareholders' Letter
January 8, 2026
Thx Pharma : THX Pharma announces the publication of its letter to shareholders
January 8, 2026
Thx Pharma : THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer
January 7, 2026
THX Pharma : announces the strong success of its approximately EUR 8 million capital increase to support its continued development and strengthen its financial structure
November 13, 2025
Thx Pharma : THX Pharma announces the strong success of its approximately EUR 8 million capital increase to support its continued development and strengthen its financial structure
November 13, 2025
THX Pharma : announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
October 23, 2025
Thx Pharma : THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
October 23, 2025
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
September 29, 2025